{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:38:33Z","timestamp":1790890713464,"version":"4.1.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>From fingerstick blood glucose monitoring and mechanical insulin pens in the 1970s to modern automated insulin delivery systems, rapidly progressing advances in diabetes technology are transforming management options for people with diabetes, particularly those with type 1 diabetes but also, increasingly, people with type 2 diabetes. However, access to life-changing diabetes technologies is neither uniform nor universally covered, and there is no one size fits all approach. In this position statement, we emphasise to healthcare professionals the importance of supporting individuals with diabetes to access and use the right diabetes technology according to personal needs, capabilities and preferences. In doing so, we highlight the equal importance of avoiding disparities in the provision of diabetes technology by challenging preconceived barriers, which can be overcome with education and determination. We also make a series of suggestions for action to advance the more widespread adoption of diabetes technology while minimising the \u2018digital divide\u2019.<\/jats:p>","DOI":"10.1007\/s00125-025-06651-9","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T20:02:08Z","timestamp":1773345728000},"page":"1393-1412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2426-8955","authenticated-orcid":false,"given":"Daniela","family":"Bruttomesso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4894-9819","authenticated-orcid":false,"given":"John R.","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Alexander","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Hanaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard W.","family":"Holl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Sherr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Bergenstal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2493-1304","authenticated-orcid":false,"given":"Lutz","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"6651_CR1","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee (2024) 7. Diabetes technology: standards of care in diabetes\u20142025. Diabetes Care 48(Suppl 1):S146\u2013S66. https:\/\/doi.org\/10.2337\/dc25-S007","DOI":"10.2337\/dc25-S007"},{"issue":"11","key":"6651_CR2","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.2337\/dci21-0043","volume":"44","author":"RIG Holt","year":"2021","unstructured":"Holt RIG, DeVries JH, Hess-Fischl A et al (2021) The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 44(11):2589\u20132625. https:\/\/doi.org\/10.2337\/dci21-0043","journal-title":"Diabetes Care"},{"issue":"1","key":"6651_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-022-05744-z","volume":"66","author":"JL Sherr","year":"2023","unstructured":"Sherr JL, Heinemann L, Fleming GA et al (2023) Automated insulin delivery: benefits, challenges, and recommendations. A consensus report of the joint diabetes technology working group of the European Association for the Study of Diabetes and the American Diabetes Association. Diabetologia 66(1):3\u201322. https:\/\/doi.org\/10.1007\/s00125-022-05744-z","journal-title":"Diabetologia"},{"issue":"9","key":"6651_CR4","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.2337\/dci23-0001","volume":"46","author":"F Hill-Briggs","year":"2023","unstructured":"Hill-Briggs F, Fitzpatrick SL (2023) Overview of social determinants of health in the development of diabetes. Diabetes Care 46(9):1590\u20131598. https:\/\/doi.org\/10.2337\/dci23-0001","journal-title":"Diabetes Care"},{"key":"6651_CR5","doi-asserted-by":"publisher","first-page":"e63288","DOI":"10.2196\/63288","volume":"8","author":"A Sj\u00f6str\u00f6m","year":"2024","unstructured":"Sj\u00f6str\u00f6m A, Hajdarevic S, H\u00f6rnsten \u00c5, Isaksson U (2024) eHealth literacy and health-related internet use among Swedish primary health care visitors: cross-sectional questionnaire study. JMIR Form Res 8:e63288. https:\/\/doi.org\/10.2196\/63288","journal-title":"JMIR Form Res"},{"key":"6651_CR6","doi-asserted-by":"publisher","first-page":"e53932","DOI":"10.2196\/53932","volume":"26","author":"RL Tisdale","year":"2024","unstructured":"Tisdale RL, Purmal C, Kalwani N et al (2024) Opportunities to address specialty care deserts and the digital divide through the veterans health administration\u2019s telehealth hub-and-spoke cardiology clinic: retrospective cohort study. J Med Internet Res 26:e53932. https:\/\/doi.org\/10.2196\/53932","journal-title":"J Med Internet Res"},{"issue":"1","key":"6651_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00125-021-05578-1","volume":"65","author":"A Jeyam","year":"2022","unstructured":"Jeyam A, Gibb FW, McKnight JA et al (2022) Flash monitor initiation is associated with improvements in HbA(1c) levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study. Diabetologia 65(1):159\u2013172. https:\/\/doi.org\/10.1007\/s00125-021-05578-1","journal-title":"Diabetologia"},{"issue":"6","key":"6651_CR8","doi-asserted-by":"publisher","first-page":"e3842","DOI":"10.1002\/dmrr.3842","volume":"40","author":"S Di Molfetta","year":"2024","unstructured":"Di Molfetta S, Di Gioia L, Caruso I et al (2024) Efficacy and safety of different hybrid closed loop systems for automated insulin delivery in people with type 1 diabetes: a systematic review and network meta-analysis. Diabetes Metab Res Rev 40(6):e3842. https:\/\/doi.org\/10.1002\/dmrr.3842","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"6651_CR9","doi-asserted-by":"publisher","first-page":"e70043","DOI":"10.1002\/edm2.70043","volume":"8","author":"S Fisker","year":"2025","unstructured":"Fisker S, Christensen M, Bach E, Bibby BM, Hansen KW (2025) Long-term performance of two systems for automated insulin delivery in adults with type 1 diabetes: an observational study. Endocrinol Diabetes Metab 8(3):e70043. https:\/\/doi.org\/10.1002\/edm2.70043","journal-title":"Endocrinol Diabetes Metab"},{"key":"6651_CR10","doi-asserted-by":"publisher","unstructured":"Folk S, Zappe J, Wyne K, Dungan KM (2025) Comparative effectiveness of hybrid closed-loop automated insulin delivery systems among patients with type 1 diabetes. J Diabetes Sci Technol 19(5):1374\u20131384. https:\/\/doi.org\/10.1177\/19322968241234948","DOI":"10.1177\/19322968241234948"},{"key":"6651_CR11","unstructured":"DigiBete (2025) Type 1 technology & resources. Available from: https:\/\/www.digibete.org\/type-1-technology-resources\/. Accessed: 16 Jan 2025"},{"issue":"11","key":"6651_CR12","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1007\/s13300-024-01654-y","volume":"15","author":"S Di Molfetta","year":"2024","unstructured":"Di Molfetta S, Rossi A, Boscari F, Irace C, Laviola L, Bruttomesso D (2024) Criteria for personalised choice of a continuous glucose monitoring system: an expert opinion. Diabetes Ther 15(11):2263\u20132278. https:\/\/doi.org\/10.1007\/s13300-024-01654-y","journal-title":"Diabetes Ther"},{"issue":"5","key":"6651_CR13","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s00125-015-3513-z","volume":"58","author":"L Heinemann","year":"2015","unstructured":"Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL (2015) Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetologia 58(5):862\u2013870. https:\/\/doi.org\/10.1007\/s00125-015-3513-z","journal-title":"Diabetologia"},{"issue":"12","key":"6651_CR14","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.2337\/dci17-0043","volume":"40","author":"JR Petrie","year":"2017","unstructured":"Petrie JR, Peters AL, Bergenstal RM, Holl RW, Fleming GA, Heinemann L (2017) Improving the clinical value and utility of CGM systems: issues and recommendations: a joint statement of the European association for the study of diabetes and the American diabetes association diabetes technology working group. Diabetes Care 40(12):1614\u20131621. https:\/\/doi.org\/10.2337\/dci17-0043","journal-title":"Diabetes Care"},{"key":"6651_CR15","doi-asserted-by":"publisher","unstructured":"Sherr JL, Heinemann L, Fleming GA et al (2022) Automated insulin delivery: benefits, challenges, and recommendations. A consensus report of the joint diabetes technology working group of the European association for the study of diabetes and the American\u00a0Diabetes Association. Diabetes Care\u00a045(12):3058\u20133074. https:\/\/doi.org\/10.2337\/dci22-0018","DOI":"10.2337\/dci22-0018"},{"issue":"1","key":"6651_CR16","doi-asserted-by":"publisher","first-page":"bvae210","DOI":"10.1210\/jendso\/bvae210","volume":"9","author":"RB Conway","year":"2024","unstructured":"Conway RB, Snell-Bergeon J, Honda-Kohmo K et al (2024) Disparities in diabetes technology uptake in youth and young adults with type 1 diabetes: a global perspective. J Endocr Soc 9(1):bvae210. https:\/\/doi.org\/10.1210\/jendso\/bvae210","journal-title":"J Endocr Soc"},{"key":"6651_CR17","unstructured":"Scottish Government (2023) Increasing access to diabetes technology. Available from: https:\/\/www.gov.scot\/news\/increasing-access-to-diabetes-technology. Accessed: 2 Dec 2025"},{"key":"6651_CR18","doi-asserted-by":"publisher","unstructured":"Nimri R, Phillip M (2025) Automated insulin delivery systems for treatment of type 1 diabetes: strategies for optimal performance. Horm Res Paediatr 98(4):371\u2013383. https:\/\/doi.org\/10.1159\/000543654","DOI":"10.1159\/000543654"},{"key":"6651_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16499","author":"W Fan","year":"2025","unstructured":"Fan W, Deng C, Xu R et al (2025) Fully automated insulin delivery systems in type 1 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab. https:\/\/doi.org\/10.1111\/dom.16499","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"6651_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13098-023-01144-4","volume":"15","author":"A Godoi","year":"2023","unstructured":"Godoi A, Reis Marques I, Padr\u00e3o EMH et al (2023) Glucose control and psychosocial outcomes with use of automated insulin delivery for 12 to 96 weeks in type 1 diabetes: a meta-analysis of randomised controlled trials. Diabetol Metab Syndr 15(1):190. https:\/\/doi.org\/10.1186\/s13098-023-01144-4","journal-title":"Diabetol Metab Syndr"},{"issue":"3","key":"6651_CR21","doi-asserted-by":"publisher","first-page":"101637","DOI":"10.1016\/j.diabet.2025.101637","volume":"51","author":"E Bismuth","year":"2025","unstructured":"Bismuth E, Joubert M, Renard E et al (2025) Practical implementation of automated insulin delivery systems in 2025: a French position statement update. Diabetes Metab 51(3):101637. https:\/\/doi.org\/10.1016\/j.diabet.2025.101637","journal-title":"Diabetes Metab"},{"issue":"6","key":"6651_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.7326\/M16-2855","volume":"167","author":"RW Beck","year":"2017","unstructured":"Beck RW, Riddlesworth TD, Ruedy K et al (2017) Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med 167(6):365\u2013374. https:\/\/doi.org\/10.7326\/M16-2855","journal-title":"Ann Intern Med"},{"issue":"22","key":"6651_CR23","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1001\/jama.2021.7444","volume":"325","author":"T Martens","year":"2021","unstructured":"Martens T, Beck RW, Bailey R et al (2021) Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. JAMA 325(22):2262\u20132272. https:\/\/doi.org\/10.1001\/jama.2021.7444","journal-title":"JAMA"},{"key":"6651_CR24","doi-asserted-by":"publisher","unstructured":"Layne JE, Jepson LH, Carite AM, Parkin CG, Bergenstal RM (2024) Long-term improvements in glycemic control with dexcom CGM use in adults with noninsulin-treated type 2 diabetes. Diabetes Technol Ther\u00a026(12):925\u2013931. https:\/\/doi.org\/10.1089\/dia.2024.0197","DOI":"10.1089\/dia.2024.0197"},{"issue":"7","key":"6651_CR25","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41574-024-00973-1","volume":"20","author":"RA Ajjan","year":"2024","unstructured":"Ajjan RA, Battelino T, Cos X et al (2024) Continuous glucose monitoring for the routine care of type 2 diabetes mellitus. Nat Rev Endocrinol 20(7):426\u2013440. https:\/\/doi.org\/10.1038\/s41574-024-00973-1","journal-title":"Nat Rev Endocrinol"},{"key":"6651_CR26","doi-asserted-by":"publisher","unstructured":"Ajjan RA, Seidu S, Riveline JP (2024) Perspective of continuous glucose monitoring-based interventions at the various stages of type 2 diabetes. Diabetes Ther\u00a015(8):1657\u20131672. https:\/\/doi.org\/10.1007\/s13300-024-01607-5","DOI":"10.1007\/s13300-024-01607-5"},{"issue":"1","key":"6651_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2337\/dc23-1520","volume":"47","author":"S Seidu","year":"2024","unstructured":"Seidu S, Kunutsor SK, Ajjan RA, Choudhary P (2024) Efficacy and safety of continuous glucose monitoring and intermittently scanned continuous glucose monitoring in patients with type 2 diabetes: a systematic review and meta-analysis of interventional evidence. Diabetes Care 47(1):169\u2013179. https:\/\/doi.org\/10.2337\/dc23-1520","journal-title":"Diabetes Care"},{"key":"6651_CR28","doi-asserted-by":"publisher","unstructured":"Spartano NL, Sultana N, Lin H et al (2025) Defining continuous glucose monitor time in range in a large, community-based cohort without diabetes. J Clin Endocrinol Metab\u00a0110(4):1128\u20131134. https:\/\/doi.org\/10.1210\/clinem\/dgae626","DOI":"10.1210\/clinem\/dgae626"},{"issue":"4","key":"6651_CR29","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1177\/19322968241242487","volume":"18","author":"SJ Zahalka","year":"2024","unstructured":"Zahalka SJ, Galindo RJ, Shah VN, Low Wang CC (2024) Continuous glucose monitoring for prediabetes: what are the best metrics? J Diabetes Sci Technol 18(4):835\u2013846. https:\/\/doi.org\/10.1177\/19322968241242487","journal-title":"J Diabetes Sci Technol"},{"issue":"14","key":"6651_CR30","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.3390\/nu16142218","volume":"16","author":"R Basiri","year":"2024","unstructured":"Basiri R, Cheskin LJ (2024) Personalized nutrition therapy without weight loss counseling produces weight loss in individuals with prediabetes who are overweight\/obese: a randomized controlled trial. Nutrients 16(14):2218. https:\/\/doi.org\/10.3390\/nu16142218","journal-title":"Nutrients"},{"key":"6651_CR31","doi-asserted-by":"publisher","first-page":"7687694","DOI":"10.1155\/2024\/7687694","volume":"2024","author":"KM Richardson","year":"2024","unstructured":"Richardson KM, Schembre SM, da Silva V et al (2024) Adding a brief continuous glucose monitoring intervention to the national diabetes prevention program: a multimethod feasibility study. J Diabetes Res 2024:7687694. https:\/\/doi.org\/10.1155\/2024\/7687694","journal-title":"J Diabetes Res"},{"issue":"7","key":"6651_CR32","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s13300-021-01081-3","volume":"12","author":"A Dehghani Zahedani","year":"2021","unstructured":"Dehghani Zahedani A, Shariat Torbaghan S, Rahili S et al (2021) Improvement in glucose regulation using a digital tracker and continuous glucose monitoring in healthy adults and those with type 2 diabetes. Diabetes Ther 12(7):1871\u20131886. https:\/\/doi.org\/10.1007\/s13300-021-01081-3","journal-title":"Diabetes Ther"},{"issue":"4","key":"6651_CR33","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1210\/clinem\/dgad652","volume":"109","author":"S Uhl","year":"2024","unstructured":"Uhl S, Choure A, Rouse B, Loblack A, Reaven P (2024) Effectiveness of continuous glucose monitoring on metrics of glycemic control in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 109(4):1119\u20131131. https:\/\/doi.org\/10.1210\/clinem\/dgad652","journal-title":"J Clin Endocrinol Metab"},{"key":"6651_CR34","doi-asserted-by":"publisher","unstructured":"Jancev M, Vissers T, Visseren FLJ et al (2024) Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis. Diabetologia\u00a067(5):798\u2013810. https:\/\/doi.org\/10.1007\/s00125-024-06107-6","DOI":"10.1007\/s00125-024-06107-6"},{"issue":"1","key":"6651_CR35","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/dom.15328","volume":"26","author":"J Lu","year":"2024","unstructured":"Lu J, Ying Z, Wang P, Fu M, Han C, Zhang M (2024) Effects of continuous glucose monitoring on glycaemic control in type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials. Diabetes Obes Metab 26(1):362\u2013372. https:\/\/doi.org\/10.1111\/dom.15328","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"6651_CR36","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1089\/dia.2023.0390","volume":"26","author":"ROM Ferreira","year":"2024","unstructured":"Ferreira ROM, Trevisan T, Pasqualotto E et al (2024) Continuous glucose monitoring systems in noninsulin-treated people with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Technol Ther 26(4):252\u2013262. https:\/\/doi.org\/10.1089\/dia.2023.0390","journal-title":"Diabetes Technol Ther"},{"key":"6651_CR37","doi-asserted-by":"publisher","unstructured":"Daly AB, Boughton CK, Nwokolo M et al (2023) Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial. Nat Med 29(1):203\u2013208. https:\/\/doi.org\/10.1038\/s41591-022-02144-z","DOI":"10.1038\/s41591-022-02144-z"},{"issue":"5","key":"6651_CR38","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1111\/dom.15462","volume":"26","author":"Y Reznik","year":"2024","unstructured":"Reznik Y, Bonnemaison E, Fagherazzi G et al (2024) The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetes. Diabetes Obes Metab 26(5):1962\u20131966. https:\/\/doi.org\/10.1111\/dom.15462","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"6651_CR39","doi-asserted-by":"publisher","first-page":"e2459348","DOI":"10.1001\/jamanetworkopen.2024.59348","volume":"8","author":"FJ Pasquel","year":"2025","unstructured":"Pasquel FJ, Davis GM, Huffman DM et al (2025) Automated insulin delivery in adults with type 2 diabetes: a nonrandomized clinical trial. JAMA Netw Open 8(2):e2459348. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.59348","journal-title":"JAMA Netw Open"},{"issue":"1","key":"6651_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/dom.15993","volume":"27","author":"GM Davis","year":"2025","unstructured":"Davis GM, Peters AL, Bode BW et al (2025) Glycaemic outcomes in adults with type 2 diabetes over 34 weeks with the Omnipod\u00ae 5 automated insulin delivery system. Diabetes Obes Metab 27(1):143\u2013154. https:\/\/doi.org\/10.1111\/dom.15993","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"6651_CR41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2337\/cd23-0025","volume":"42","author":"CJ Levy","year":"2024","unstructured":"Levy CJ, Raghinaru D, Kudva YC et al (2024) Beneficial effects of control-IQ automated insulin delivery in basal-bolus and basal-only insulin users with type 2 diabetes. Clin Diabetes 42(1):116\u2013124. https:\/\/doi.org\/10.2337\/cd23-0025","journal-title":"Clin Diabetes"},{"key":"6651_CR42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2415948","author":"YC Kudva","year":"2025","unstructured":"Kudva YC, Raghinaru D, Lum JW et al (2025) A randomized trial of automated insulin delivery in type 2 diabetes. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2415948","journal-title":"N Engl J Med"},{"issue":"5","key":"6651_CR43","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1089\/dia.2024.0586","volume":"27","author":"A Bhargava","year":"2025","unstructured":"Bhargava A, Bergenstal RM, Warren ML et al (2025) Safety and effectiveness of MiniMed(TM) 780G advanced hybrid closed-loop insulin intensification in adults with insulin-requiring type 2 diabetes. Diabetes Technol Ther 27(5):366\u2013375. https:\/\/doi.org\/10.1089\/dia.2024.0586","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"6651_CR44","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2337\/dc23-1765","volume":"47","author":"JL Sherr","year":"2024","unstructured":"Sherr JL, Laffel LM, Liu J et al (2024) Severe hypoglycemia and impaired awareness of hypoglycemia persist in people with type 1 diabetes despite use of diabetes technology: results from a cross-sectional survey. Diabetes Care 47(6):941\u2013947. https:\/\/doi.org\/10.2337\/dc23-1765","journal-title":"Diabetes Care"},{"key":"6651_CR45","doi-asserted-by":"publisher","first-page":"204201882513462","DOI":"10.1177\/20420188251346260","volume":"16","author":"SA Berry","year":"2025","unstructured":"Berry SA, Goodman I, Heller S, Iqbal A (2025) The impact of technology on impaired awareness of hypoglycaemia in type 1 diabetes. Ther Adv Endocrinol Metab 16:20420188251346260. https:\/\/doi.org\/10.1177\/20420188251346260","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"10","key":"6651_CR46","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s00125-024-06240-2","volume":"67","author":"G Maltese","year":"2024","unstructured":"Maltese G, McAuley SA, Trawley S, Sinclair AJ (2024) Ageing well with diabetes: the role of technology. Diabetologia 67(10):2085\u2013102. https:\/\/doi.org\/10.1007\/s00125-024-06240-2","journal-title":"Diabetologia"},{"issue":"8","key":"6651_CR47","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.2337\/dci23-0021","volume":"46","author":"ES Huang","year":"2023","unstructured":"Huang ES, Sinclair A, Conlin PR et al (2023) The growing role of technology in the care of older adults with diabetes. Diabetes Care 46(8):1455\u20131463. https:\/\/doi.org\/10.2337\/dci23-0021","journal-title":"Diabetes Care"},{"issue":"23","key":"6651_CR48","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1001\/jama.2020.6928","volume":"323","author":"RE Pratley","year":"2020","unstructured":"Pratley RE, Kanapka LG, Rickels MR et al (2020) Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. JAMA 323(23):2397\u20132406. https:\/\/doi.org\/10.1001\/jama.2020.6928","journal-title":"JAMA"},{"key":"6651_CR49","doi-asserted-by":"publisher","unstructured":"Adolfsson P, Hartvig NV, Kaas A, Moller JB, Hellman J (2020) Increased time in range and fewer missed bolus injections after introduction of a smart connected insulin pen. Diabetes Technol Ther\u00a022(10):709\u2013718. https:\/\/doi.org\/10.1089\/dia.2019.0411","DOI":"10.1089\/dia.2019.0411"},{"issue":"2","key":"6651_CR50","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2337\/dc21-1667","volume":"45","author":"SA McAuley","year":"2022","unstructured":"McAuley SA, Trawley S, Vogrin S et al (2022) Closed-loop insulin delivery versus sensor-augmented pump therapy in older adults with type 1 diabetes (ORACL): a randomized, crossover trial. Diabetes Care 45(2):381\u2013390. https:\/\/doi.org\/10.2337\/dc21-1667","journal-title":"Diabetes Care"},{"issue":"3","key":"6651_CR51","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/s2666-7568(22)00005-8","volume":"3","author":"CK Boughton","year":"2022","unstructured":"Boughton CK, Hartnell S, Thabit H et al (2022) Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study. Lancet Healthy Longev 3(3):e135\u2013e142. https:\/\/doi.org\/10.1016\/s2666-7568(22)00005-8","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"6651_CR52","doi-asserted-by":"publisher","first-page":"EVIDoa2400200","DOI":"10.1056\/EVIDoa2400200","volume":"4","author":"YC Kudva","year":"2025","unstructured":"Kudva YC, Henderson RJ, Kanapka LG et al (2025) Automated insulin delivery in older adults with type 1 diabetes. NEJM Evid 4(1):EVIDoa2400200. https:\/\/doi.org\/10.1056\/EVIDoa2400200","journal-title":"NEJM Evid"},{"issue":"1","key":"6651_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11892-025-01583-5","volume":"25","author":"T Idrees","year":"2025","unstructured":"Idrees T, Castro-Revoredo I, Kantipudi S, Umpierrez G (2025) Managing diabetes in older adults: current approaches in long-term care facilities. Curr Diab Rep 25(1):27. https:\/\/doi.org\/10.1007\/s11892-025-01583-5","journal-title":"Curr Diab Rep"},{"issue":"3","key":"6651_CR54","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.1097\/mpa.0000000000002424","volume":"54","author":"A Bashir","year":"2025","unstructured":"Bashir A, Joseph N, Hammond JS et al (2025) Evaluating continuous glucose monitoring after total pancreatectomy with or without islet autotransplantation: a scoping systematic review. Pancreas 54(3):e268\u2013e277. https:\/\/doi.org\/10.1097\/mpa.0000000000002424","journal-title":"Pancreas"},{"issue":"7","key":"6651_CR55","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s00592-021-01715-9","volume":"58","author":"A Rizzi","year":"2021","unstructured":"Rizzi A, Tartaglione L, Di Leo M, Alfieri S, Pitocco D (2021) Advanced hybrid closed-loop system: first successful clinical case after total pancreatectomy. Acta Diabetol 58(7):967\u2013969. https:\/\/doi.org\/10.1007\/s00592-021-01715-9","journal-title":"Acta Diabetol"},{"issue":"10","key":"6651_CR56","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1001\/jamasurg.2022.3702","volume":"157","author":"CL van Veldhuisen","year":"2022","unstructured":"van Veldhuisen CL, Latenstein AEJ, Blauw H et al (2022) Bihormonal artificial pancreas with closed-loop glucose control vs current diabetes care after total pancreatectomy: a randomized clinical trial. JAMA Surg 157(10):950\u2013957. https:\/\/doi.org\/10.1001\/jamasurg.2022.3702","journal-title":"JAMA Surg"},{"issue":"6","key":"6651_CR57","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1089\/dia.2021.0354","volume":"24","author":"KJ Scully","year":"2022","unstructured":"Scully KJ, Palani G, Zheng H, Moheet A, Putman MS (2022) The effect of control IQ hybrid closed loop technology on glycemic control in adolescents and adults with cystic fibrosis-related diabetes. Diabetes Technol Ther 24(6):446\u2013452. https:\/\/doi.org\/10.1089\/dia.2021.0354","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"6651_CR58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jcf.2022.07.013","volume":"22","author":"S Kumar","year":"2023","unstructured":"Kumar S, Soldatos G, Ranasinha S, Teede H, Pallin M (2023) Continuous glucose monitoring versus self-monitoring of blood glucose in the management of cystic fibrosis related diabetes: a systematic review and meta-analysis. J Cyst Fibros 22(1):39\u201349. https:\/\/doi.org\/10.1016\/j.jcf.2022.07.013","journal-title":"J Cyst Fibros"},{"issue":"1","key":"6651_CR59","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2337\/dc23-1411","volume":"47","author":"JS Sherwood","year":"2024","unstructured":"Sherwood JS, Castellanos LE, O\u2019Connor MY et al (2024) Randomized trial of the insulin-only iLet bionic pancreas for the treatment of cystic fibrosis- related diabetes. Diabetes Care 47(1):101\u2013108. https:\/\/doi.org\/10.2337\/dc23-1411","journal-title":"Diabetes Care"},{"key":"6651_CR60","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee (2024) 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142025. Diabetes Care 48(Suppl 1):S181\u2013S206. https:\/\/doi.org\/10.2337\/dc25-S009","DOI":"10.2337\/dc25-S009"},{"issue":"4","key":"6651_CR61","doi-asserted-by":"publisher","first-page":"101654","DOI":"10.1016\/j.diabet.2025.101654","volume":"51","author":"Q Perrier","year":"2025","unstructured":"Perrier Q, Lablanche S, Rakotoarisoa L et al (2025) Automated insulin delivery after beta-cell replacement failure in people living with type 1 diabetes. Diabetes Metab 51(4):101654. https:\/\/doi.org\/10.1016\/j.diabet.2025.101654","journal-title":"Diabetes Metab"},{"issue":"80","key":"6651_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/jypl3536","volume":"28","author":"A Asgharzadeh","year":"2024","unstructured":"Asgharzadeh A, Patel M, Connock M et al (2024) Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling. Health Technol Assess 28(80):1\u2013190. https:\/\/doi.org\/10.3310\/jypl3536","journal-title":"Health Technol Assess"},{"issue":"11","key":"6651_CR63","doi-asserted-by":"publisher","first-page":"e15432","DOI":"10.1111\/dme.15432","volume":"41","author":"P Adolfsson","year":"2024","unstructured":"Adolfsson P, Heringhaus A, Sjunnesson K, Mehkri L, Bolin K (2024) Cost-effectiveness of the tandem t: Slim X2 with control-IQ technology automated insulin delivery system in children and adolescents with type 1 diabetes in Sweden. Diabet Med 41(11):e15432. https:\/\/doi.org\/10.1111\/dme.15432","journal-title":"Diabet Med"},{"key":"6651_CR64","doi-asserted-by":"publisher","unstructured":"Hirsch IB, Burugapalli BS, Brandner L et al (2024) Impact of continuous glucose monitoring on emergency department visits and all-cause hospitalization rates among Medicaid beneficiaries with type 2 diabetes treated with multiple daily insulin or basal insulin therapy. J Manag Care Spec Pharm 30(10-b Suppl):S21-S29. https:\/\/doi.org\/10.18553\/jmcp.2024.30.10-b.s21","DOI":"10.18553\/jmcp.2024.30.10-b.s21"},{"issue":"6","key":"6651_CR65","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1007\/s12325-024-02851-8","volume":"41","author":"KL Hannah","year":"2024","unstructured":"Hannah KL, Nemlekar PM, Green CR, Norman GJ (2024) Reduction in diabetes-related hospitalizations and medical costs after Dexcom G6 continuous glucose monitor initiation in people with type 2 diabetes using intensive insulin therapy. Adv Ther 41(6):2299\u20132306. https:\/\/doi.org\/10.1007\/s12325-024-02851-8","journal-title":"Adv Ther"},{"key":"6651_CR66","doi-asserted-by":"publisher","unstructured":"Harris S, Cimino S, Nguyen Y, Szafranski K, Poon Y (2024) Cost-effectiveness of freestyle libre for glucose self-management among people with diabetes mellitus: a Canadian private payer perspective. Diabetes Ther\u00a016(2):169\u2013186. https:\/\/doi.org\/10.1007\/s13300-024-01677-5","DOI":"10.1007\/s13300-024-01677-5"},{"issue":"1","key":"6651_CR67","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1089\/dia.2022.0271","volume":"25","author":"B Guerci","year":"2023","unstructured":"Guerci B, Roussel R, Levrat-Guillen F et al (2023) Important decrease in hospitalizations for acute diabetes events following freestyle libre system initiation in people with type 2 diabetes on basal insulin therapy in France. Diabetes Technol Ther 25(1):20\u201330. https:\/\/doi.org\/10.1089\/dia.2022.0271","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"6651_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00125-024-06289-z","volume":"68","author":"D Nathanson","year":"2025","unstructured":"Nathanson D, Eeg-Olofsson K, Spelman T et al (2025) Intermittently scanned continuous glucose monitoring compared with blood glucose monitoring is associated with lower HbA(1c) and a reduced risk of hospitalisation for diabetes-related complications in adults with type 2 diabetes on insulin therapies. Diabetologia 68(1):41\u201351. https:\/\/doi.org\/10.1007\/s00125-024-06289-z","journal-title":"Diabetologia"},{"issue":"12","key":"6651_CR69","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.2337\/dc24-0690","volume":"47","author":"K Eeg-Olofsson","year":"2024","unstructured":"Eeg-Olofsson K, Nathanson D, Spelman T et al (2024) Initiation of intermittently scanned continuous glucose monitoring is associated with reduced hospitalization for acute diabetes events and cardiovascular complications in adults with type 1 diabetes. Diabetes Care 47(12):2164\u20132171. https:\/\/doi.org\/10.2337\/dc24-0690","journal-title":"Diabetes Care"},{"issue":"2","key":"6651_CR70","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2337\/dc21-1666","volume":"45","author":"SR Johnson","year":"2022","unstructured":"Johnson SR, Holmes-Walker DJ, Chee M et al (2022) Universal subsidized continuous glucose monitoring funding for young people with type 1 diabetes: uptake and outcomes over 2 years, a population-based study. Diabetes Care 45(2):391\u2013397. https:\/\/doi.org\/10.2337\/dc21-1666","journal-title":"Diabetes Care"},{"issue":"11","key":"6651_CR71","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.2337\/dc22-0951","volume":"45","author":"AJ Pease","year":"2022","unstructured":"Pease AJ, Zoungas S, Callander E et al (2022) Nationally subsidized continuous glucose monitoring: a cost-effectiveness analysis. Diabetes Care 45(11):2611\u20132619. https:\/\/doi.org\/10.2337\/dc22-0951","journal-title":"Diabetes Care"},{"key":"6651_CR72","doi-asserted-by":"publisher","unstructured":"Biester T, Berget C, Boughton C et al (2024)\u00a0International Society for Pediatric and Adolescent Diabetes\u00a0clinical practice consensus guidelines 2024: diabetes technologies: insulin delivery. Hormone Res Paediatr 2024:97(6):636\u2013662. https:\/\/doi.org\/10.1159\/000543034","DOI":"10.1159\/000543034"},{"issue":"4","key":"6651_CR73","doi-asserted-by":"publisher","first-page":"550","DOI":"10.2337\/cd23-0092","volume":"42","author":"GD Simonson","year":"2024","unstructured":"Simonson GD, Holt EH, Grady M, Hurrell G, Gaudiani LM, Bergenstal RM (2024) Unleashing the potential of blood glucose monitoring data with the ambulatory glucose profile report. Clin Diabetes 42(4):550\u2013560. https:\/\/doi.org\/10.2337\/cd23-0092","journal-title":"Clin Diabetes"},{"issue":"10","key":"6651_CR74","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3949\/ccjm.91a.23090","volume":"91","author":"TW Martens","year":"2024","unstructured":"Martens TW, Simonson GD, Bergenstal RM (2024) Using continuous glucose monitoring data in daily clinical practice. Cleve Clin J Med 91(10):611\u2013620. https:\/\/doi.org\/10.3949\/ccjm.91a.23090","journal-title":"Cleve Clin J Med"},{"key":"6651_CR75","doi-asserted-by":"publisher","first-page":"e45890","DOI":"10.2196\/45890","volume":"8","author":"L Loomba","year":"2023","unstructured":"Loomba L, Bonanno S, Arellano D, Crossen S, Glaser N (2023) Disparities in insulin pump use among Spanish-speaking children with type 1 diabetes compared to their non-Hispanic white peers: mixed methods study. JMIR Diabetes 8:e45890. https:\/\/doi.org\/10.2196\/45890","journal-title":"JMIR Diabetes"},{"issue":"4","key":"6651_CR76","doi-asserted-by":"publisher","first-page":"e004229","DOI":"10.1136\/bmjdrc-2024-004229","volume":"12","author":"AF Walker","year":"2024","unstructured":"Walker AF, Haller MJ, Addala A et al (2024) Not all healthcare inequities in diabetes are equal: a comparison of two medically underserved cohorts. BMJ Open Diabetes Res Care 12(4):e004229. https:\/\/doi.org\/10.1136\/bmjdrc-2024-004229","journal-title":"BMJ Open Diabetes Res Care"},{"key":"6651_CR77","doi-asserted-by":"publisher","unstructured":"Addala A, Hanes S, Naranjo D, Maahs DM, Hood KK (2021) Provider implicit bias impacts pediatric type 1 diabetes technology recommendations in the united states: findings from the gatekeeper study. J Diabetes Sci Technol:19322968211006476. https:\/\/doi.org\/10.1177\/19322968211006476","DOI":"10.1177\/19322968211006476"},{"issue":"1","key":"6651_CR78","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2337\/dc20-0257","volume":"44","author":"A Addala","year":"2021","unstructured":"Addala A, Auzanneau M, Miller K et al (2021) A decade of disparities in diabetes technology use and hba1c in pediatric type 1 diabetes: a transatlantic comparison. Diabetes Care 44(1):133\u2013140. https:\/\/doi.org\/10.2337\/dc20-0257","journal-title":"Diabetes Care"},{"issue":"9","key":"6651_CR79","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1089\/dia.2022.0042","volume":"24","author":"O Odugbesan","year":"2022","unstructured":"Odugbesan O, Addala A, Nelson G et al (2022) Implicit racial-ethnic and insurance-mediated bias to recommending diabetes technology: insights from T1D exchange multicenter pediatric and adult diabetes provider cohort. Diabetes Technol Ther 24(9):619\u2013627. https:\/\/doi.org\/10.1089\/dia.2022.0042","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"6651_CR80","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/pedi.13139","volume":"22","author":"TH Lipman","year":"2021","unstructured":"Lipman TH, Smith JA, Patil O, Willi SM, Hawkes CP (2021) Racial disparities in treatment and outcomes of children with type 1 diabetes. Pediatr Diabetes 22(2):241\u2013248. https:\/\/doi.org\/10.1111\/pedi.13139","journal-title":"Pediatr Diabetes"},{"issue":"10","key":"6651_CR81","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1111\/dom.15774","volume":"26","author":"PM Patel","year":"2024","unstructured":"Patel PM, Thomas D, Liu Z, Aldrich-Renner S, Clemons M, Patel BV (2024) Systematic review of disparities in continuous glucose monitoring and insulin pump utilization in the United States: Key themes and evidentiary gaps. Diabetes Obes Metab 26(10):4293\u20134301. https:\/\/doi.org\/10.1111\/dom.15774","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"6651_CR82","doi-asserted-by":"publisher","first-page":"e2445316","DOI":"10.1001\/jamanetworkopen.2024.45316","volume":"7","author":"A Wallia","year":"2024","unstructured":"Wallia A, Agarwal S, Owen AL et al (2024) Disparities in continuous glucose monitoring among patients receiving care in federally qualified health centers. JAMA Netw Open 7(11):e2445316. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.45316","journal-title":"JAMA Netw Open"},{"issue":"3","key":"6651_CR83","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2337\/cd21-0026","volume":"39","author":"P Prahalad","year":"2021","unstructured":"Prahalad P, Ebekozien O, Alonso GT et al (2021) Multi-clinic quality improvement initiative increases continuous glucose monitoring use among adolescents and young adults with type 1 diabetes. Clin Diabetes 39(3):264\u2013271. https:\/\/doi.org\/10.2337\/cd21-0026","journal-title":"Clin Diabetes"},{"key":"6651_CR84","doi-asserted-by":"publisher","unstructured":"Mathias P, Mahali LP, Agarwal S (2023) Erratum. Targeting technology in underserved adults with type 1 diabetes: effect of diabetes practice transformations on improving equity in CGM prescribing behaviors. Diabetes Care 2022;45:2231-2237. Diabetes Care 46(1):222. https:\/\/doi.org\/10.2337\/dc23-er01","DOI":"10.2337\/dc23-er01"},{"issue":"4s","key":"6651_CR85","doi-asserted-by":"publisher","first-page":"102106","DOI":"10.1016\/j.japh.2024.102106","volume":"64","author":"C Beldon","year":"2024","unstructured":"Beldon C, Rogers K, Johnson A et al (2024) Assessment of a community pharmacist remote monitoring service in patients using continuous glucose monitors. J Am Pharm Assoc (2003) 64(4s):102106. https:\/\/doi.org\/10.1016\/j.japh.2024.102106","journal-title":"J Am Pharm Assoc (2003)"},{"key":"6651_CR86","doi-asserted-by":"publisher","unstructured":"Weinstock RS, Raghinaru D, Gal RL et al (2024) Older adults benefit from virtual support for continuous glucose monitor use but require longer visits. J Diabetes Sci Technol:19322968241294250. https:\/\/doi.org\/10.1177\/19322968241294250","DOI":"10.1177\/19322968241294250"},{"issue":"11","key":"6651_CR87","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.3390\/ijerph21111420","volume":"21","author":"Z Jafar","year":"2024","unstructured":"Jafar Z, Quick JD, Rim\u00e1nyi E, Musuka G (2024) Social media and digital inequity: reducing health inequities by closing the digital divide. Int J Environ Res Public Health 21(11):1420. https:\/\/doi.org\/10.3390\/ijerph21111420","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"6651_CR88","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11883-024-01249-9","volume":"27","author":"DS Kim","year":"2024","unstructured":"Kim DS, Eltahir AA, Ngo S, Rodriguez F (2024) Bridging the gap: how accounting for social determinants of health can improve digital health equity in cardiovascular medicine. Curr Atheroscler Rep 27(1):9. https:\/\/doi.org\/10.1007\/s11883-024-01249-9","journal-title":"Curr Atheroscler Rep"},{"issue":"8","key":"6651_CR89","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s00125-021-05456-w","volume":"64","author":"LJ Reid","year":"2021","unstructured":"Reid LJ, Gibb FW, Colhoun H et al (2021) Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin. Diabetologia 64(8):1725\u20131736. https:\/\/doi.org\/10.1007\/s00125-021-05456-w","journal-title":"Diabetologia"},{"issue":"6","key":"6651_CR90","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1177\/19322968221101629","volume":"17","author":"HK Akturk","year":"2023","unstructured":"Akturk HK, Snell-Bergeon J, Shah VN (2023) Health care professionals\u2019 perspectives on use of diabetes technologies for managing visually impaired patients with diabetes. J Diabetes Sci Technol 17(6):1610\u20131613. https:\/\/doi.org\/10.1177\/19322968221101629","journal-title":"J Diabetes Sci Technol"},{"issue":"8","key":"6651_CR91","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1089\/dia.2021.0524","volume":"24","author":"L Ekhlaspour","year":"2022","unstructured":"Ekhlaspour L, Town M, Raghinaru D, Lum JW, Brown SA, Buckingham BA (2022) Glycemic outcomes in baseline hemoglobin A1C subgroups in the international diabetes closed-loop trial. Diabetes Technol Ther 24(8):588\u2013591. https:\/\/doi.org\/10.1089\/dia.2021.0524","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"6651_CR92","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1089\/dia.2021.0217","volume":"23","author":"GP Forlenza","year":"2021","unstructured":"Forlenza GP, Breton MD, Kovatchev BP (2021) Candidate selection for hybrid closed loop systems. Diabetes Technol Ther 23(11):760\u2013762. https:\/\/doi.org\/10.1089\/dia.2021.0217","journal-title":"Diabetes Technol Ther"},{"key":"6651_CR93","doi-asserted-by":"publisher","first-page":"e59824","DOI":"10.2196\/59824","volume":"7","author":"A Podwojniak","year":"2024","unstructured":"Podwojniak A, Flemming J, Tan IJ, Ghani H, Neubauer Z, Jones A (2024) Cutaneous adverse effects from diabetes devices in pediatric patients with type 1 diabetes mellitus: systematic review. JMIR Dermatol 7:e59824. https:\/\/doi.org\/10.2196\/59824","journal-title":"JMIR Dermatol"},{"issue":"6","key":"6651_CR94","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1177\/19322968241253285","volume":"18","author":"S Passanisi","year":"2024","unstructured":"Passanisi S, Galletta F, Bombaci B et al (2024) Device-related skin reactions increase emotional burden in youths with type 1 diabetes and their parents. J Diabetes Sci Technol 18(6):1293\u20131299. https:\/\/doi.org\/10.1177\/19322968241253285","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"6651_CR95","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1089\/dia.2022.0513","volume":"25","author":"M Diedisheim","year":"2023","unstructured":"Diedisheim M, Pecquet C, Julla JB et al (2023) Prevalence and description of the skin reactions associated with adhesives in diabetes technology devices in an adult population: results of the CUTADIAB study. Diabetes Technol Ther 25(4):279\u2013286. https:\/\/doi.org\/10.1089\/dia.2022.0513","journal-title":"Diabetes Technol Ther"},{"key":"6651_CR96","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.57187\/s.3366","volume":"154","author":"DG Rohner","year":"2024","unstructured":"Rohner DG, Burget L, Henzen C, Fischli S (2024) Impact on diabetes control and patient-reported outcomes of a newer implantable continuous glucose monitoring system (Eversense\u00ae CGM System): a single-centre retro- and prospective observational study. Swiss Med Wkly 154:3366. https:\/\/doi.org\/10.57187\/s.3366","journal-title":"Swiss Med Wkly"},{"issue":"6","key":"6651_CR97","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1177\/19322968231187661","volume":"17","author":"T Tian","year":"2023","unstructured":"Tian T, Aaron RE, Huang J et al (2023) Lipohypertrophy and insulin: an update from the diabetes technology society. J Diabetes Sci Technol 17(6):1711\u20131721. https:\/\/doi.org\/10.1177\/19322968231187661","journal-title":"J Diabetes Sci Technol"},{"key":"6651_CR98","doi-asserted-by":"publisher","unstructured":"Hirsch IB, Khakpour D, Joseph J et al (2024) The DERMIS study: methodologies, results, and implications for the future. J Diabetes Sci Technol:19322968241298005. https:\/\/doi.org\/10.1177\/19322968241298005","DOI":"10.1177\/19322968241298005"},{"issue":"S2","key":"6651_CR99","doi-asserted-by":"publisher","first-page":"S254","DOI":"10.1089\/dia.2018.0080","volume":"20","author":"LH Messer","year":"2018","unstructured":"Messer LH, Berget C, Beatson C, Polsky S, Forlenza GP (2018) Preserving skin integrity with chronic device use in diabetes. Diabetes Technol Ther 20(S2):S254-s264. https:\/\/doi.org\/10.1089\/dia.2018.0080","journal-title":"Diabetes Technol Ther"},{"key":"6651_CR100","unstructured":"Panther (n.d.) Diabetes technology deciphered. Available from: https:\/\/www.pantherprogram.org\/. Accessed: 11 Jan 2025"},{"issue":"3","key":"6651_CR101","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/dme.14234","volume":"37","author":"T Kubiak","year":"2020","unstructured":"Kubiak T, Priesterroth L, Barnard-Kelly KD (2020) Psychosocial aspects of diabetes technology. Diabet Med 37(3):448\u2013454. https:\/\/doi.org\/10.1111\/dme.14234","journal-title":"Diabet Med"},{"key":"6651_CR102","doi-asserted-by":"publisher","first-page":"111566","DOI":"10.1016\/j.diabres.2024.111566","volume":"209","author":"A Zare Dehnavi","year":"2024","unstructured":"Zare Dehnavi A, Elmitwalli I, Alsharif HOH et al (2024) Effects of ADHD and ADHD treatment on glycemic management in type 1 diabetes: a systematic review and meta-analysis of observational studies. Diabetes Res Clin Pract 209:111566. https:\/\/doi.org\/10.1016\/j.diabres.2024.111566","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"6651_CR103","doi-asserted-by":"publisher","first-page":"e15338","DOI":"10.1111\/dme.15338","volume":"41","author":"KD Barnard-Kelly","year":"2024","unstructured":"Barnard-Kelly KD, Mart\u00ednez-Brocca MA, Glatzer T, Oliver N (2024) Identifying the deficiencies of currently available CGM to improve uptake and benefit. Diabet Med 41(8):e15338. https:\/\/doi.org\/10.1111\/dme.15338","journal-title":"Diabet Med"},{"key":"6651_CR104","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2147\/MDER.S312858","volume":"14","author":"ME Pauley","year":"2021","unstructured":"Pauley ME, Berget C, Messer LH, Forlenza GP (2021) Barriers to uptake of insulin technologies and novel solutions. Med Devices (Auckl) 14:339\u2013354. https:\/\/doi.org\/10.2147\/MDER.S312858","journal-title":"Med Devices (Auckl)"},{"issue":"6","key":"6651_CR105","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1089\/dia.2016.0375","volume":"19","author":"PV Commissariat","year":"2017","unstructured":"Commissariat PV, Boyle CT, Miller KM et al (2017) Insulin pump use in young children with type 1 diabetes: sociodemographic factors and parent-reported barriers. Diabetes Technol Ther 19(6):363\u2013369. https:\/\/doi.org\/10.1089\/dia.2016.0375","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"6651_CR106","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1037\/fsh0000485","volume":"38","author":"KP Garza","year":"2020","unstructured":"Garza KP, Weil LEG, Anderson LM et al (2020) You, me, and diabetes: Intimacy and technology among adults with T1D and their partners. Fam Syst Health 38(4):418\u201327. https:\/\/doi.org\/10.1037\/fsh0000485","journal-title":"Fam Syst Health"},{"key":"6651_CR107","doi-asserted-by":"publisher","first-page":"109998","DOI":"10.1016\/j.diabres.2022.109998","volume":"190","author":"WH Polonsky","year":"2022","unstructured":"Polonsky WH, Hood KK, Levy CJ et al (2022) How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod\u00ae 5 System. Diabetes Res Clin Pract 190:109998. https:\/\/doi.org\/10.1016\/j.diabres.2022.109998","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"6651_CR108","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12916-024-03396-x","volume":"22","author":"SM Ng","year":"2024","unstructured":"Ng SM, Wright NP, Yardley D et al (2024) Long-term assessment of the NHS hybrid closed-loop real-world study on glycaemic outcomes, time-in-range, and quality of life in children and young people with type 1 diabetes. BMC Med 22(1):175. https:\/\/doi.org\/10.1186\/s12916-024-03396-x","journal-title":"BMC Med"},{"issue":"7","key":"6651_CR109","doi-asserted-by":"publisher","first-page":"e14863","DOI":"10.1111\/dme.14863","volume":"39","author":"SM Ng","year":"2022","unstructured":"Ng SM, Katkat N, Day H, Hubbard R, Quinn M, Finnigan L (2022) Real-world prospective observational single-centre study: hybrid closed loop improves HbA1c, time-in-range and quality of life for children, young people and their carers. Diabet Med 39(7):e14863. https:\/\/doi.org\/10.1111\/dme.14863","journal-title":"Diabet Med"},{"key":"6651_CR110","doi-asserted-by":"publisher","first-page":"e43535","DOI":"10.2196\/43535","volume":"7","author":"K Cyranka","year":"2023","unstructured":"Cyranka K, Matejko B, Juza A et al (2023) Improvement of selected psychological parameters and quality of life of patients with type 1 diabetes mellitus undergoing transition from multiple daily injections and self-monitoring of blood glucose directly to the MiniMed 780G advanced hybrid closed-loop system: post hoc analysis of a randomized control study. JMIR Form Res 7:e43535. https:\/\/doi.org\/10.2196\/43535","journal-title":"JMIR Form Res"},{"issue":"2","key":"6651_CR111","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/dom.15351","volume":"26","author":"Y Reznik","year":"2024","unstructured":"Reznik Y, Carvalho M, Fendri S et al (2024) Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed-loop? The CLOSE AP+ randomized controlled trial. Diabetes Obes Metab 26(2):622\u2013630. https:\/\/doi.org\/10.1111\/dom.15351","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"6651_CR112","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1007\/s00431-024-05551-1","volume":"183","author":"A Jalilova","year":"2024","unstructured":"Jalilova A, Pilan B, Demir G et al (2024) The psychosocial outcomes of advanced hybrid closed-loop system in children and adolescents with type 1 diabetes. Eur J Pediatr 183(7):3095\u20133103. https:\/\/doi.org\/10.1007\/s00431-024-05551-1","journal-title":"Eur J Pediatr"},{"issue":"11","key":"6651_CR113","doi-asserted-by":"publisher","first-page":"e15425","DOI":"10.1111\/dme.15425","volume":"41","author":"CS Kelly","year":"2024","unstructured":"Kelly CS, Nguyen H, Chapman KS, Wolf WA (2024) The emotional burden of type 1 diabetes: a cross-sectional study to understand associations between diabetes distress and glucose metrics in adulthood. Diabet Med 41(11):e15425. https:\/\/doi.org\/10.1111\/dme.15425","journal-title":"Diabet Med"},{"issue":"3","key":"6651_CR114","doi-asserted-by":"publisher","first-page":"e080053","DOI":"10.1136\/bmjopen-2023-080053","volume":"14","author":"JT Lorenzen","year":"2024","unstructured":"Lorenzen JT, Madsen KP, Cleal B et al (2024) Associations between use of diabetes technology and diabetes distress: a Danish cross-sectional survey of adults with type 1 diabetes. BMJ Open 14(3):e080053. https:\/\/doi.org\/10.1136\/bmjopen-2023-080053","journal-title":"BMJ Open"},{"issue":"5","key":"6651_CR115","doi-asserted-by":"publisher","first-page":"e15312","DOI":"10.1111\/dme.15312","volume":"41","author":"FJ Snoek","year":"2024","unstructured":"Snoek FJ, Anarte-Ortiz MT, Anderbro T et al (2024) Roles and competencies of the clinical psychologist in adult diabetes care-A consensus report. Diabet Med 41(5):e15312. https:\/\/doi.org\/10.1111\/dme.15312","journal-title":"Diabet Med"},{"issue":"12","key":"6651_CR116","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/1753-0407.13454","volume":"15","author":"P Natale","year":"2023","unstructured":"Natale P, Chen S, Chow CK et al (2023) Patient experiences of continuous glucose monitoring and sensor-augmented insulin pump therapy for diabetes: a systematic review of qualitative studies. J Diabetes 15(12):1048\u20131069. https:\/\/doi.org\/10.1111\/1753-0407.13454","journal-title":"J Diabetes"},{"issue":"10","key":"6651_CR117","doi-asserted-by":"publisher","first-page":"e14906","DOI":"10.1111\/dme.14906","volume":"39","author":"C Fallon","year":"2022","unstructured":"Fallon C, Jones E, Oliver N, Reddy M, Avari P (2022) The impact of socio-economic deprivation on access to diabetes technology in adults with type 1 diabetes. Diabet Med 39(10):e14906. https:\/\/doi.org\/10.1111\/dme.14906","journal-title":"Diabet Med"},{"issue":"7","key":"6651_CR118","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11892-022-01470-3","volume":"22","author":"S Agarwal","year":"2022","unstructured":"Agarwal S, Simmonds I, Myers AK (2022) The use of diabetes technology to address inequity in health outcomes: limitations and opportunities. Curr Diab Rep 22(7):275\u2013281. https:\/\/doi.org\/10.1007\/s11892-022-01470-3","journal-title":"Curr Diab Rep"},{"issue":"3","key":"6651_CR119","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1089\/dia.2013.0192","volume":"16","author":"JC Pickup","year":"2014","unstructured":"Pickup JC, Yemane N, Brackenridge A, Pender S (2014) Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey. Diabetes Technol Ther 16(3):145\u2013149. https:\/\/doi.org\/10.1089\/dia.2013.0192","journal-title":"Diabetes Technol Ther"},{"issue":"9","key":"6651_CR120","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1089\/dia.2016.07281.sf","volume":"18","author":"D Deiss","year":"2016","unstructured":"Deiss D, Adolfsson P, Alkemade-van ZM et al (2016) Insulin infusion set use: european perspectives and recommendations. Diabetes Technol Ther 18(9):517\u2013524. https:\/\/doi.org\/10.1089\/dia.2016.07281.sf","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"6651_CR121","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1210\/endrev\/bnac022","volume":"44","author":"M Phillip","year":"2023","unstructured":"Phillip M, Nimri R, Bergenstal RM et al (2023) Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. Endocr Rev 44(2):254\u2013280. https:\/\/doi.org\/10.1210\/endrev\/bnac022","journal-title":"Endocr Rev"},{"key":"6651_CR122","doi-asserted-by":"publisher","first-page":"1464365","DOI":"10.3389\/fcdhc.2024.1464365","volume":"5","author":"B Cari\u0107","year":"2024","unstructured":"Cari\u0107 B, Marin S, Malinovi\u0107-Pan\u010di\u0107 J, Male\u0161evi\u0107 G, Mirni\u0107 D (2024) The success of insulin pump therapy: importance of education of patients and health professionals. Front Clin Diabetes Healthc 5:1464365. https:\/\/doi.org\/10.3389\/fcdhc.2024.1464365","journal-title":"Front Clin Diabetes Healthc"},{"issue":"3","key":"6651_CR123","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1177\/1043659617723074","volume":"29","author":"M Jang","year":"2018","unstructured":"Jang M, Johnson CM, D\u2019Eramo-Melkus G, Vorderstrasse AA (2018) Participation of racial and ethnic minorities in technology-based interventions to self-manage type 2 diabetes: a scoping review. J Transcult Nurs 29(3):292\u2013307. https:\/\/doi.org\/10.1177\/1043659617723074","journal-title":"J Transcult Nurs"},{"issue":"6","key":"6651_CR124","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1177\/1932296820963630","volume":"14","author":"D Kerr","year":"2020","unstructured":"Kerr D, Warshaw H (2020) Clouds and silver linings: COVID-19 pandemic is an opportune moment to democratize diabetes care through telehealth. J Diabetes Sci Technol 14(6):1107\u20131110. https:\/\/doi.org\/10.1177\/1932296820963630","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"6651_CR125","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1089\/tmj.2023.0270","volume":"30","author":"A Sarwal","year":"2024","unstructured":"Sarwal A, Lim J, Sarwal A (2024) Telemedicine for the underserved racial and ethnic minorities during COVID-19 and beyond. Telemed J E Health 30(6):1588\u20131593. https:\/\/doi.org\/10.1089\/tmj.2023.0270","journal-title":"Telemed J E Health"},{"issue":"4","key":"6651_CR126","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1177\/1932296820932903","volume":"14","author":"RJ Galindo","year":"2020","unstructured":"Galindo RJ, Aleppo G, Klonoff DC et al (2020) Implementation of continuous glucose monitoring in the hospital: emergent considerations for remote glucose monitoring during the COVID-19 pandemic. J Diabetes Sci Technol 14(4):822\u2013832. https:\/\/doi.org\/10.1177\/1932296820932903","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"6651_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/med.0000000000000693","volume":"29","author":"C Gothong","year":"2022","unstructured":"Gothong C, Singh LG, Satyarengga M, Spanakis EK (2022) Continuous glucose monitoring in the hospital: an update in the era of COVID-19. Curr Opin Endocrinol Diabetes Obes 29(1):1\u20139. https:\/\/doi.org\/10.1097\/med.0000000000000693","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"10","key":"6651_CR128","doi-asserted-by":"publisher","first-page":"e2336876","DOI":"10.1001\/jamanetworkopen.2023.36876","volume":"6","author":"G Aleppo","year":"2023","unstructured":"Aleppo G, Gal RL, Raghinaru D et al (2023) Comprehensive telehealth model to support diabetes self-management. JAMA Netw Open 6(10):e2336876. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.36876","journal-title":"JAMA Netw Open"},{"key":"6651_CR129","doi-asserted-by":"publisher","unstructured":"Hood K, Bergenstal RM, Cushman T et al (2025) Patient-reported outcomes improve with a virtual diabetes care model that includes continuous glucose monitoring. Telemed J E Health 31(1):75\u201384. https:\/\/doi.org\/10.1089\/tmj.2024.0093","DOI":"10.1089\/tmj.2024.0093"},{"issue":"23","key":"6651_CR130","doi-asserted-by":"publisher","first-page":"7359","DOI":"10.3390\/jcm13237359","volume":"13","author":"F Fogliazza","year":"2024","unstructured":"Fogliazza F, Sambati V, Iovane B, Lazzeroni P, Street ME, Esposito S (2024) Telemedicine for managing type 1 diabetes in children and adolescents before and after the COVID-19 pandemic. J Clin Med 13(23):7359. https:\/\/doi.org\/10.3390\/jcm13237359","journal-title":"J Clin Med"},{"key":"6651_CR131","doi-asserted-by":"publisher","first-page":"100686","DOI":"10.1016\/j.lanepe.2023.100686","volume":"32","author":"D Dardari","year":"2023","unstructured":"Dardari D, Franc S, Charpentier G et al (2023) Hospital stays and costs of telemedical monitoring versus standard follow-up for diabetic foot ulcer: an open-label randomised controlled study. Lancet Reg Health Eur 32:100686. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100686","journal-title":"Lancet Reg Health Eur"},{"key":"6651_CR132","doi-asserted-by":"publisher","first-page":"e58441","DOI":"10.2196\/58441","volume":"12","author":"R Wettstein","year":"2024","unstructured":"Wettstein R, Sedaghat-Hamedani F, Heinze O et al (2024) A remote patient monitoring system with feedback mechanisms using a smartwatch: concept, implementation, and evaluation based on the activeDCM randomized controlled trial. JMIR Mhealth Uhealth 12:e58441. https:\/\/doi.org\/10.2196\/58441","journal-title":"JMIR Mhealth Uhealth"},{"issue":"7","key":"6651_CR133","first-page":"1","volume":"18","author":"HQ Ontario","year":"2018","unstructured":"Ontario HQ (2018) Remote monitoring of implantable cardioverter-defibrillators, cardiac resynchronization therapy and permanent pacemakers: a health technology assessment. Ont Health Technol Assess Ser 18(7):1\u2013199","journal-title":"Ont Health Technol Assess Ser"},{"issue":"9","key":"6651_CR134","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.3390\/s24092675","volume":"24","author":"E Matijevich","year":"2024","unstructured":"Matijevich E, Minty E, Bray E, Bachus C, Hajizadeh M, Liden B (2024) A multi-faceted digital health solution for monitoring and managing diabetic foot ulcer risk: a case series. Sensors (Basel) 24(9):2675. https:\/\/doi.org\/10.3390\/s24092675","journal-title":"Sensors (Basel)"},{"issue":"4","key":"6651_CR135","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1210\/clinem\/dgab859","volume":"107","author":"P Prahalad","year":"2022","unstructured":"Prahalad P, Ding VY, Zaharieva DP et al (2022) Teamwork, targets, technology, and tight control in newly diagnosed type 1 diabetes: the pilot 4T study. J Clin Endocrinol Metab 107(4):998\u20131008. https:\/\/doi.org\/10.1210\/clinem\/dgab859","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"6651_CR136","doi-asserted-by":"publisher","first-page":"e64928","DOI":"10.7759\/cureus.64928","volume":"16","author":"O AlQassab","year":"2024","unstructured":"AlQassab O, Kanthajan T, Pandey M et al (2024) Evaluating the impact of telemedicine on diabetes management in rural communities: a systematic review. Cureus 16(7):e64928. https:\/\/doi.org\/10.7759\/cureus.64928","journal-title":"Cureus"},{"key":"6651_CR137","doi-asserted-by":"publisher","first-page":"e64635","DOI":"10.2196\/64635","volume":"27","author":"JJ Shih","year":"2025","unstructured":"Shih JJ, Kuznia M, Nouri S et al (2025) Differences in telemedicine use for patients with diabetes in an academic versus safety net health system: retrospective cohort study. J Med Internet Res 27:e64635. https:\/\/doi.org\/10.2196\/64635","journal-title":"J Med Internet Res"},{"issue":"2","key":"6651_CR138","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s00125-023-06049-5","volume":"67","author":"J Jendle","year":"2024","unstructured":"Jendle J, Adolfsson P, Choudhary P et al (2024) A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU\/UK\/US perspective. Diabetologia 67(2):236\u2013245. https:\/\/doi.org\/10.1007\/s00125-023-06049-5","journal-title":"Diabetologia"},{"issue":"10","key":"6651_CR139","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1089\/dia.2024.0073","volume":"26","author":"GP Forlenza","year":"2024","unstructured":"Forlenza GP, Tabatabai I, Lewis DM (2024) Point-counterpoint: the need for Do-It-Yourself (DIY) Open Source (OS) AID systems in type 1 diabetes management. Diabetes Technol Ther 26(10):689\u2013699. https:\/\/doi.org\/10.1089\/dia.2024.0073","journal-title":"Diabetes Technol Ther"},{"key":"6651_CR140","doi-asserted-by":"publisher","unstructured":"Messori M, Toffanin C, Del Favero\u00a0S, De Nicolao\u00a0G, Cobelli C, Magni L (2019) Model individualization for artificial pancreas. Comput Methods Programs Biomed 171:133\u2013140. https:\/\/doi.org\/10.1016\/j.cmpb.2016.06.006","DOI":"10.1016\/j.cmpb.2016.06.006"},{"issue":"1","key":"6651_CR141","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/btm2.10119","volume":"4","author":"D Shi","year":"2019","unstructured":"Shi D, Dassau E, Doyle FJ 3rd (2019) Multivariate learning framework for long-term adaptation in the artificial pancreas. Bioeng Transl Med 4(1):61\u201374. https:\/\/doi.org\/10.1002\/btm2.10119","journal-title":"Bioeng Transl Med"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06651-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-025-06651-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06651-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:08:05Z","timestamp":1777028885000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-025-06651-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":141,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["6651"],"URL":"https:\/\/doi.org\/10.1007\/s00125-025-06651-9","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We would like to thank J. Zhao and K. Hultberg for editorial support; several academic colleagues for their helpful comments; and M. Hill (ADA) and P. Niemann (EASD). We would also like to thank the invited reviewers and the EASD\u2019s Committee for Clinical Affairs and the ADA\u2019s Professional Practice Committee for their input and assistance. J. Zhao and K. Hultberg were\/are staff members of Kinexum. Their work was provided pro bono by the firm. No industry contributions were used for this purpose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}},{"value":"No honoraria were received by members of the Joint ADA\u2013EASD Diabetes Technology Working Group (AEDTWG) for writing this manuscript or associated meetings. Most of the members of the AEDTWG collaborate with industry as listed below; however, industry had no impact on the manuscript and its content. DB has received congress invitations, honoraria and consultancy fees from Abbott, Eli Lilly, Menarini, Novo Nordisk, Roche Diabetes Care, Sanofi, Terumo, Theras and Ypsomed and served on advisory board panels for Roche Diabetes Care and Terumo. JRP is a recipient of support in kind (donation and discounting of equipment and consumables for a clinical trial) from Dexcom and has served on an advisory board for Abbott Diabetes Care, as well as several companies that manufacture pharmaceuticals used in the treatment of diabetes. ME has conducted clinical trials and\/or research collaborations with, served on advisory boards for or received speakers fees and\/or travel support from Abbott Diabetes Care, AstraZeneca, Dexcom, Eli Lilly, Medtronic, Novo Nordisk, Roche, Sanofi, Pila Pharma and Zucara. GAF is the Executive Chairman of Kinexum, which advises multiple health product companies, including insulin manufacturers. Relevant device companies advised include Abbott, Biolinq, CMC Magnetics, Diabeloop, Hagar, Know Labs, Modular Medical, SFC Fluidics and Surf Bio. He was formerly the Group Leader of the Division of Metabolism and Endocrine Drug Products at the US FDA. HH has received congress invitations, honoraria and consultancy fees from Abbott, Eli Lilly, Medtronic, Novo Nordisk, Sanofi, AstraZeneca and Insulet, and served on advisory board panels for Diabeloop and Insulet. RWH coordinates the German\/Austrian DPV initiative, which has been supported by Boehringer Ingelheim, Eli Lilly, Medtronic, Novo Nordisk and Roche through institutional research grants. RWH did not receive any personal honoraria. JLS has conducted clinical trials for Abbott Diabetes Care, Dexcom, JDRF\/Breakthrough T1D, Insulet, Medtronic and Provention Bio and has received in-kind support for research studies from Dexcom and Medtronic. She has consulted for Abbott Diabetes, Insulet, Medscape, Medtronic, Vertex and Ypsomed. She has been a member of advisory boards for Cecelia Health, Insulet, MannKind, Medtronic Diabetes, StartUp Health T1D Moonshot and Vertex. RMB has conducted clinical trials, consulted or served on the scientific advisory boards for Abbott Diabetes Care, Ascensia, Bayer, Becton Dickinson, CeQur, Dexcom, Eli Lilly, Insulet, Johnson & Johnson, Medtronic, Novo Nordisk, Roche Diabetes Care and Sanofi. He receives no personal income from these activities; all payments go to the non-profit Park Nicollet Institute. LH is a partner of Profil Institut f\u00fcr Stoffwechselforschung in Neuss, Germany, diateam GmbH, Bad Mergentheim, and Science Consulting in Diabetes GmbH, D\u00fcsseldorf. He is a member of the advisory boards for Medtronic, Roche Diagnostics and Liom. He is also on the board of directors for Lifecare. ALP has served on advisory boards for Medscape and Vertex. She has received grant funding from Insulet and Zucara and devices from Abbott Diabetes Care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"No datasets were generated or analysed in the production of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors received no specific grant from any funding agency in the public, commercial or not-for-profit sectors for the production of this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors substantially contributed to the conception or design of the work or the acquisition, analysis or interpretation of data; were involved in drafting the article and reviewing it critically for important intellectual content; and approved the final version to be published.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}